© Fraunhofer EMB
Asthma is one of the most common respiratory diseases worldwide, affecting more than 235 million patients. It is often more difficult to diagnose in children than in adults. An early diagnosis is especially important for children as to prevent severe attacks of the disease. A team of researchers at the Fraunhofer Research Institution for Marine Biotechnology and Cell Technology EMB has joined forces with some high-tech companies to develop a rapid test that requires only a drop of blood to diagnose asthma. To do this, the partners use machine learning.